SELLAS Life Sciences Group, Inc. Common Stock

SLS

...

SLS: SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Show SLS Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of SLS by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by SLS's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on SLS's company Twitter account

WallStreetBets

Number of mentions of SLS in WallStreetBets Daily Discussion

SLS News

Recent insights relating to SLS

CNBC Recommendations

Recent picks made for SLS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SLS

Corporate Flights

Flights by private jets registered to SLS